Early Impact of the State Innovation Models Initiative on Diagnosed Diabetes Prevalence Among Adults and Hospitalizations Among Diagnosed Adults

Overview

Journal Med Care

Specialty Health Services

Date 2019 Jul 12

PMID 31295167

Citations 2

Authors

Brent D Fulton

Nianyi Hong

Hector P Rodriguez

Affiliations

Soon will be listed here.

Abstract

Background: The State Innovation Models (SIM) Initiative invested $254 million in 6 states in Round 1 to accelerate delivery system and payment reforms.

Objective: The objective of this study was to examine the association of early SIM implementation and diagnosed diabetes prevalence among adults and hospitalization rates among diagnosed adults.

Research Design: Quasi-experimental design compares diagnosed diabetes prevalence and hospitalization rates before SIM (2010-2013) and during early implementation (2014) in 6 SIM states versus 6 comparison states. County-level, difference-in-differences regression models were estimated.

Subjects: The annual average of 4.5 million adults aged 20+ diagnosed with diabetes with 1.4 million hospitalizations in 583 counties across 12 states.

Measures: Diagnosed diabetes prevalence among adults and hospitalization rates per 1000 diagnosed adults.

Results: Compared with the pre-SIM period, diagnosed diabetes prevalence increased in SIM counties by 0.65 percentage points (from 10.22% to 10.87%) versus only 0.10 percentage points (from 9.64% to 9.74%) in comparison counties, a difference-in-differences of 0.55 percentage points. The difference-in-differences regression estimates ranged from 0.49 to 0.53 percentage points (P<0.01). Regression results for ambulatory care-sensitive condition and all-cause hospitalization rates were inconsistent across models with difference-in-differences estimates ranging from -5.34 to -0.37 and from -13.16 to 0.92, respectively.

Conclusions: SIM Round 1 was associated with higher diagnosed diabetes prevalence among adults after a year of implementation, likely because of SIM's emphasis on detection and care management. SIM was not associated with lower hospitalization rates among adults diagnosed with diabetes, but the SIM's long-term impact on hospitalizations should be assessed.

Citing Articles

Effect of State-Led Delivery System and Payment Reforms on Population-Level Detection and Management of Diabetes.

Rodriguez H, Fulton B, Phillips A, Rubio K Diabetes Care. 2022; 45(10):2255-2263.

PMID: 35972261 PMC: 9643138. DOI: 10.2337/dc21-2425.

The Early Impact of the Centers for Medicare & Medicaid Services State Innovation Models Initiative on 30-Day Hospital Readmissions Among Adults With Diabetes.

Rodriguez H, Fulton B, Phillips A Med Care. 2020; 58 Suppl 6 Suppl 1:S22-S30.

PMID: 32412950 PMC: 7324298. DOI: 10.1097/MLR.0000000000001276.

References

Jain S, Shrank W . The CMS Innovation Center: delivering on the promise of payment and delivery reform. J Gen Intern Med. 2014; 29(9):1221-3. PMC: 4139533. DOI: 10.1007/s11606-014-2844-7. View

Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

Roberts E, McWilliams J, Hatfield L, Gerovich S, Chernew M, Gilstrap L . Changes in Health Care Use Associated With the Introduction of Hospital Global Budgets in Maryland. JAMA Intern Med. 2018; 178(2):260-268. PMC: 5838791. DOI: 10.1001/jamainternmed.2017.7455. View

Daw J, Hatfield L . Matching and Regression to the Mean in Difference-in-Differences Analysis. Health Serv Res. 2018; 53(6):4138-4156. PMC: 6232412. DOI: 10.1111/1475-6773.12993. View

Sentell T, Cheng Y, Saito E, Seto T, Miyamura J, Mau M . The Burden of Diagnosed and Undiagnosed Diabetes in Native Hawaiian and Asian American Hospitalized Patients. J Clin Transl Endocrinol. 2015; 2(4):115-124. PMC: 4576722. DOI: 10.1016/j.jcte.2015.08.002. View

McWilliams J, Hatfield L, Chernew M, Landon B, Schwartz A . Early Performance of Accountable Care Organizations in Medicare. N Engl J Med. 2016; 374(24):2357-66. PMC: 4963149. DOI: 10.1056/NEJMsa1600142. View

Austin P, Stuart E . Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015; 34(28):3661-79. PMC: 4626409. DOI: 10.1002/sim.6607. View

Ryan A, Burgess Jr J, Dimick J . Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences. Health Serv Res. 2014; 50(4):1211-35. PMC: 4545355. DOI: 10.1111/1475-6773.12270. View

. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018; 41(5):917-928. PMC: 5911784. DOI: 10.2337/dci18-0007. View

10.

Kaufman B, Spivack B, Stearns S, Song P, OBrien E . Impact of Accountable Care Organizations on Utilization, Care, and Outcomes: A Systematic Review. Med Care Res Rev. 2017; 76(3):255-290. DOI: 10.1177/1077558717745916. View

11.

Kenrik Duru O, Mangione C, Rodriguez H, Ross-Degnan D, Wharam J, Black B . Introductory Overview of the Natural Experiments for Translation in Diabetes 2.0 (NEXT-D2) Network: Examining the Impact of US Health Policies and Practices to Prevent Diabetes and Its Complications. Curr Diab Rep. 2018; 18(2):8. PMC: 8910460. DOI: 10.1007/s11892-018-0977-5. View

12.

Dall T, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N . The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014; 37(12):3172-9. DOI: 10.2337/dc14-1036. View

13.

Walker R, Smalls B, Campbell J, Williams J, Egede L . Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review. Endocrine. 2014; 47(1):29-48. PMC: 7029167. DOI: 10.1007/s12020-014-0195-0. View

14.

Sortso C, Komkova A, Sandbaek A, Griffin S, Emneus M, Lauritzen T . Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2018; 61(6):1306-1314. PMC: 7617192. DOI: 10.1007/s00125-018-4594-2. View

15.

Bang H, Robins J . Doubly robust estimation in missing data and causal inference models. Biometrics. 2006; 61(4):962-73. DOI: 10.1111/j.1541-0420.2005.00377.x. View

16.

Hughes L, Peltz A, Conway P . State innovation model initiative: a state-led approach to accelerating health care system transformation. JAMA. 2015; 313(13):1317-8. DOI: 10.1001/jama.2015.2017. View

17.

Garrido M, Kelley A, Paris J, Roza K, Meier D, Morrison R . Methods for constructing and assessing propensity scores. Health Serv Res. 2014; 49(5):1701-20. PMC: 4213057. DOI: 10.1111/1475-6773.12182. View

18.

Daw J, Hatfield L . Matching in Difference-in-Differences: between a Rock and a Hard Place. Health Serv Res. 2018; 53(6):4111-4117. PMC: 6232434. DOI: 10.1111/1475-6773.13017. View

19.

Jackson G, Powers B, Chatterjee R, Bettger J, Kemper A, Hasselblad V . The patient centered medical home. A systematic review. Ann Intern Med. 2014; 158(3):169-78. DOI: 10.7326/0003-4819-158-3-201302050-00579. View

20.

Hoff T, Weller W, DePuccio M . The patient-centered medical home: a review of recent research. Med Care Res Rev. 2012; 69(6):619-44. DOI: 10.1177/1077558712447688. View